Pacira BioSciences Inc
PCRXLatest QuantConomy context for PCRX: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Pacira BioSciences Inc
QuantConomy has a structured record for PCRX. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- PCRX
- Name
- Pacira BioSciences Inc
- Coverage
- 3 market/data records
- Sources
- fmp alphavantage alpaca sec nasdaq openfigi
Recent signals for PCRX
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| earnings release | neutral | 40 | Jan 8, 12:00 AM | PCRX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-08. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings release | neutral | 40 | Feb 26, 12:00 AM | PCRX filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-26. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| executive change | neutral | 90 | Jun 11, 08:35 PM | PCRX filed 8-K: Director or Officer Changes, Shareholder Vote Results, Other Events - 2 material events - [very strong neutral signal] |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| PCRX | NASDAQ | fmp | Pacira BioSciences, Inc. |
| PCRX | NASDAQ | alphavantage | Pacira BioSciences Inc |
| PCRX | NASDAQ | alpaca | Pacira BioSciences, Inc. Common Stock |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | RIKER LAUREN | Senior Vice President, Finance | sale | 6,115 | $23.50 | $143,703 | 4 on EDGAR |
| Jun 10, 2026 | BIGAL MARCELO | Insider | grant | 6,405 | $0.00 | $0 | 4 on EDGAR |
| Jun 10, 2026 | Hirawat Samit | Insider | grant | 6,405 | $0.00 | $0 | 4 on EDGAR |
| Jun 10, 2026 | CHRISTIE CHRISTOPHER | Insider | grant | 6,405 | $0.00 | $0 | 4 on EDGAR |
| Jun 10, 2026 | WIGGANS THOMAS G | Insider | grant | 32,675 | — | — | 4 on EDGAR |
| Jun 10, 2026 | YANG MICHAEL J. | Insider | grant | 6,405 | $0.00 | $0 | 4 on EDGAR |
| Jun 10, 2026 | Froimson Mark | Insider | grant | 6,405 | $0.00 | $0 | 4 on EDGAR |
| Jun 10, 2026 | Young Alethia | Insider | grant | 6,405 | $0.00 | $0 | 4 on EDGAR |
| Jun 10, 2026 | Brege Laura | Insider | grant | 6,405 | $0.00 | $0 | 4 on EDGAR |
| Jun 3, 2026 | SLONIN JONATHAN | Chief Medical Officer | other | 4,728 | $22.32 | $105,529 | 4 on EDGAR |
| Jun 3, 2026 | RIKER LAUREN | Senior Vice President, Finance | other | 3,187 | $22.32 | $71,134 | 4 on EDGAR |
| Jun 3, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | other | 8,528 | $22.32 | $190,345 | 4 on EDGAR |
| Apr 23, 2026 | Cross Shawn | Chief Financial Officer | exercise | 12,941 | $16.45 | $212,879 | 4 on EDGAR |
| Apr 20, 2026 | Cross Shawn | Chief Financial Officer | exercise | 7,714 | $16.45 | $126,895 | 4 on EDGAR |
| Mar 17, 2026 | Froimson Mark | Insider | sale | 500 | $21.81 | $10,905 | 4 on EDGAR |
| Mar 17, 2026 | SLONIN JONATHAN | Chief Medical Officer | sale | 3,261 | $22.82 | $74,416 | 4 on EDGAR |
| Feb 11, 2026 | Cross Shawn | Chief Financial Officer | grant | 49,091 | $0.00 | $0 | 4 on EDGAR |
| Feb 11, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | grant | 54,546 | $0.00 | $0 | 4 on EDGAR |
| Jan 30, 2026 | WILLIAMS KRISTEN | Chief Administrative Officer | other | 17,134 | $20.54 | $351,932 | 4 on EDGAR |
| Jan 30, 2026 | RIKER LAUREN | Senior Vice President, Finance | other | 2,751 | $20.54 | $56,506 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query PCRX context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access